Galectin 3 has been associated with pulmonary hypertension and fibrosis, and Barman and colleagues have used CRISPR‐mediated deletion of Gal3 to examine its role in pulmonary hypertension in rats.101. Here, LGALS3 is linked to pulmonary arterial hypertension.